![]()
|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 37, 27046-27057, September 14, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Center for Immunology and Microbial Disease, Albany Medical College, Albany, New York 12208
The roles of the HIV1 protein Vpr in virus replication and pathogenesis remain unclear. Expression of Vpr in dividing cells causes cell cycle arrest in G2. Vpr also facilitates low titer infection of terminally differentiated macrophages, enhances transcription, promotes apoptosis, and targets cellular uracil N-glycosylase for degradation. Using co-immunoprecipitation and tandem mass spectroscopy, we found that HIV1 Vpr engages a DDB1- and cullin4A-containing ubiquitin-ligase complex through VprBP/DCAF1. HIV2 Vpr has two Vpr-like proteins, Vpr and Vpx, which cause G2 arrest and facilitate macrophage infection, respectively. HIV2 Vpr, but not Vpx, engages the same set of proteins. We further demonstrate that the interaction between Vpr and the ubiquitin-ligase components as well as further assembly of the ubiquitin-ligase are necessary for Vpr-mediated G2 arrest. Our data support a model in which Vpr engages the ubiquitin ligase to deplete a cellular factor that is required for cell cycle progression into mitosis. Vpr, thus, functions like the HIV1 proteins Vif and Vpu to usurp cellular ubiquitin ligases for viral functions.
Received for publication, May 14, 2007 , and in revised form, June 26, 2007.
* This work was supported by Albany Medical College start-up funds and an Albany Medical College bridge grant (to C. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Medical Sciences Bldg. 216, MC-151, Albany Medical College, Albany, NY 12208. Tel.: 518-262-1175; Fax: 518-262-6161; E-mail: DeNoroC{at}mail.AMC.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. L. DeHart, A. Bosque, R. S. Harris, and V. Planelles Human Immunodeficiency Virus Type 1 Vif Induces Cell Cycle Delay via Recruitment of the Same E3 Ubiquitin Ligase Complex That Targets APOBEC3 Proteins for Degradation J. Virol., September 15, 2008; 82(18): 9265 - 9272. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Le Rouzic, M. Morel, D. Ayinde, N. Belaidouni, J. Letienne, C. Transy, and F. Margottin-Goguet Assembly with the Cul4A-DDB1DCAF1 Ubiquitin Ligase Protects HIV-1 Vpr from Proteasomal Degradation J. Biol. Chem., August 1, 2008; 283(31): 21686 - 21692. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, S. Feng, F. Chen, H. Chen, J. Wang, C. McCall, Y. Xiong, and X. W. Deng Arabidopsis DDB1-CUL4 ASSOCIATED FACTOR1 Forms a Nuclear E3 Ubiquitin Ligase with DDB1 and CUL4 That Is Involved in Multiple Plant Developmental Processes PLANT CELL, June 1, 2008; 20(6): 1437 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kitayama, Y. Miura, Y. Ando, S. Hoshino, Y. Ishizaka, and Y. Koyanagi Human Immunodeficiency Virus Type 1 Vpr Inhibits Axonal Outgrowth through Induction of Mitochondrial Dysfunction J. Virol., March 1, 2008; 82(5): 2528 - 2542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. DeHart and V. Planelles Human Immunodeficiency Virus Type 1 Vpr Links Proteasomal Degradation and Checkpoint Activation J. Virol., February 1, 2008; 82(3): 1066 - 1072. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |